跳至主要内容
临床试验/CTRI/2022/10/046583
CTRI/2022/10/046583尚未招募2/3 期

Randomised clinical trial to study efficacy of Eranda Sneha(5ml)with Shunthi Kwatha(50ml) in the management of Katishoola with special reference to Chakradatta.

Sane Guruji Arogya Kendra1 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2022年10月31日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
入组人数
35
试验地点
1
主要终点
Primary outcome is assessment of Katishoola with pain scale

研究概览

简要总结

The study will be done on the patients selected on the basis on inclusion criteria, The initial assessment will be done on 1st day. Then the treatment will be started (Erand sneha 5ml with sunthi kwatha 50ml before dinner for seven days. On 8th day follow up will be done. Result of 1st day assessment will be compared with 8th day assessment. Result will be drawn after discussion and conclusion based on statistical analysis

研究设计

研究类型
Interventional
分配方式
Random Number Table
盲法
Open Label

入排标准

年龄范围
30.00 Year(s) 至 60.00 Year(s)(—)

入选标准

  • 1.Patients having symptom of Katishool more than 7 days and less than 3 months. 2.Avarodha Janya Samprapti. 3.No specific and major pathology of degenerative changes
  • Male and Female.

排除标准

  • 1.Taking NSAIDs 2.Patient having inborn structural deformities.
  • Diagnosed with Fracture of Lumbar Spine etc.
  • and needs surgical intervention 4.Patients having other joint deformities or diseases which are not related to Katishoola.
  • Katishoola is associated with known case of Cardiac disease, Pulmonary TB, Pregnancy, Paralysis, Neurological disorder, HIV or any other relevant pathology.

结局指标

主要结局

Primary outcome is assessment of Katishoola with pain scale

时间窗: intervention for consecutive 7 days

次要结局

  • Comparative analysis of pain and functional improvement

研究者

申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验